These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 10826401

  • 1. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K, Kahan T, Dahl M.
    Am J Hypertens; 2000 May; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [Abstract] [Full Text] [Related]

  • 2. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
    Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL.
    Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF.
    J Hum Hypertens; 2000 Apr 01; 14(4):263-9. PubMed ID: 10805052
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.
    Neldam S, Forsén B, Multicentre Study Group.
    Drugs Aging; 2001 Apr 01; 18(3):225-32. PubMed ID: 11302289
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial.
    Association of Black Cardiologists (ABC) Candesartan Study Group.
    Heart Dis; 2000 Apr 01; 2(6):392-9. PubMed ID: 11728289
    [Abstract] [Full Text] [Related]

  • 6. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.
    Tanser PH, Campbell LM, Carranza J, Karrash J, Toutouzas P, Watts R.
    Am J Hypertens; 2000 Feb 01; 13(2):214-8. PubMed ID: 10701823
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.
    Ogihara T, Arakawa K.
    J Hum Hypertens; 1999 Jan 01; 13 Suppl 1():S27-31; discussion S33-4. PubMed ID: 10076918
    [Abstract] [Full Text] [Related]

  • 8. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Jan 01; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 9. A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy.
    Campbell M, Sonkodi S, Soucek M, Wiecek A.
    Clin Exp Hypertens; 2001 May 01; 23(4):345-55. PubMed ID: 11349825
    [Abstract] [Full Text] [Related]

  • 10. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.
    Oparil S.
    Am J Cardiol; 1999 Nov 18; 84(10A):35S-41S. PubMed ID: 10588093
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care.
    Edes I, Multicentre Study Group.
    Clin Drug Investig; 2009 Nov 18; 29(5):293-304. PubMed ID: 19366271
    [Abstract] [Full Text] [Related]

  • 12. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL, Pêgo M, Marquez E, Pujol M, Olivan J, Alegría E, Sagastagoitia-Gorostiza JD, Gonzalez-Juanatey JR.
    Clin Drug Investig; 2007 Nov 18; 27(6):407-17. PubMed ID: 17506591
    [Abstract] [Full Text] [Related]

  • 13. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
    Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T, Effect Study Group.
    Blood Press; 2001 Nov 18; 10(1):43-51. PubMed ID: 11332334
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB, Reilly PA.
    Clin Ther; 2001 Jun 18; 23(6):833-50. PubMed ID: 11440284
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H.
    J Hum Hypertens; 1997 Sep 18; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE, Lins LE, Hermansson K.
    J Hypertens; 1999 Feb 18; 17(2):293-302. PubMed ID: 10067800
    [Abstract] [Full Text] [Related]

  • 17. Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists.
    Sever PS.
    J Hum Hypertens; 1999 Jan 18; 13 Suppl 1():S3-10; discussion S33-4. PubMed ID: 10076915
    [Abstract] [Full Text] [Related]

  • 18. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
    Zanchetti A, Omboni S.
    Am J Hypertens; 2001 Feb 18; 14(2):129-34. PubMed ID: 11243303
    [Abstract] [Full Text] [Related]

  • 19. Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil.
    Sever PS.
    J Hypertens Suppl; 1997 Dec 18; 15(6):S9-12. PubMed ID: 9493121
    [Abstract] [Full Text] [Related]

  • 20. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P, Reismann J, Pohlmeyer H, Düsing R.
    Dtsch Med Wochenschr; 2001 May 11; 126(19):547-50. PubMed ID: 11402910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.